New study provides clues to early T cell immune responses in acute HIV infection

February 15, 2017
HIV infecting a human cell. Credit: NIH

A new study has shown that potent HIV-specific CD8+ T cells that are able to kill HIV-producing cells and reduce the seeding of the HIV reservoir are only detected at peak viremia in acute HIV infection. Findings from the study, which was led by the U.S. Military HIV Research Program (MHRP) of the Walter Reed Army Institute of Research, were published Wednesday in Science Translational Medicine.

HIV-specific CD8+ T cells are that kill cells infected with HIV. CD8+ T cells play a critical role in controlling HIV viremia and could be important in reducing overall numbers of HIV-infected cells in approaches to eradicate HIV.

Researchers studied HIV-specific CD8+ T cells in samples from MHRP's unique RV254 acute infection study, a cohort of individuals who are recruited at the earliest stages of acute HIV infection (AHI), usually within weeks of infection, and placed on ART immediately. RV254 is led by Dr. Jintanat Ananworanich, MHRP's Associate Director for Therapeutics Research, and conducted in collaboration with the Thai Red Cross

In the current study, researchers were able to track immune response through three distinct AHI stages. They found that the HIV-specific CD8+ T cells generated during AHI stage 1 and 2, prior to peak viremia, are delayed in expanding and acquiring effector functions, meaning they are less effective at controlling HIV replication.

In contrast, the fully differentiated HIV-specific CD8+ T cells found at peak viremia, or AHI stage 3, were associated with a steeper viral load decrease after ART initiation. Importantly, these fully-differentiated cells able persist after ART initiation correlated with a decreased seeding of the HIV reservoir.

"Fully differentiated HIV-specific CD8+ T cells were still present two weeks after ART initiation, but their numbers decline drastically," said Dr. Lydie Trautmann, MHRP's Chief of Cellular Immunology and senior author of the paper. "Interventions aiming at prolonging their survival might have profound impact on the HIV reservoir size. The remaining challenge over the next few years will be to find ways to induce and maintain these potent HIV-specific CD8+ effector T cells by immune interventions."

The viral reservoir poses a critical challenge in the quest to cure HIV since it contains in which the HIV virus can lie dormant for many years, thereby avoiding elimination by antiretroviral therapy.

Explore further: Early antiretroviral therapy dramatically reduces HIV DNA set point

More information: "Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection," Science Translational Medicine, stm.sciencemag.org/lookup/doi/10.1126/scitranslmed.aag1809

Related Stories

Study observes potential breakthrough in treatment of HIV

June 17, 2016

A new study conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected cells, providing an important ...

Why some people may not respond to the malaria vaccine

December 20, 2016

Generating protective immunity against the early liver stage of malaria infection is feasible but has been difficult to achieve in regions with high rates of malaria infection. Researchers at the University of Washington ...

Overcoming immune exhaustion from chronic HIV infection

December 3, 2015

Chronic HIV infection results in exhaustion of the immune system, a phenomenon characterized by dysfunctional HIV-specific killer T cells. The exhausted T cells display inhibitory proteins on their surface, and scientists ...

Recommended for you

Researchers identify a new HIV reservoir

April 17, 2017

HIV cure research to date has focused on clearing the virus from T cells, a type of white blood cell that is an essential part of the immune system. Yet investigators in the Division of Infectious Diseases at the University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.